Aurora Cannabis (ACBFF) Stock Price, News & Analysis

Company Overview

Aurora Cannabis Inc. is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2013, the company develops, produces and distributes cannabis and cannabis-derived products for medical and adult-use markets. Its product portfolio has included dried cannabis flower, pre-rolls, oils, softgels, vapes and other cannabis formats, offered under brands such as Aurora, CanniMed, MedReleaf and San Rafael '71.

Aurora’s medical cannabis business serves patients in Canada and international markets, while its consumer cannabis operations supply products through Canada’s regulated adult-use market. The company has also pursued international expansion through sales, distribution arrangements and local operations in selected European, Australian and other medical-cannabis markets, subject to applicable regulations.

Historically, Aurora expanded through investments in cultivation capacity, product development and acquisitions, including its acquisition of MedReleaf in 2018. In addition to cultivating and manufacturing cannabis, the company has emphasized pharmaceutical-grade production, scientific research and the development of cannabis-based products for medical applications. Miguel Martin has served as Aurora Cannabis’s chief executive officer.

Key Stats

• Today's Range: $3.87 to $3.97
• 50-Day Range: $2.67 to $4.27
• 52-Week Range: $2.20 to $12.53
• Volume: 682,851 shs
• Average Volume: 4.22 million shs
• Market Capitalization: $3.77 billion
• P/E Ratio: 32.67
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ACBFF
• CIK: N/A
• Web: auroramj.com
• Phone: 844-928-7672
• Fax: N/A
• Employees: 1,340
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 32.67
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 960,960,000
• Free Float: N/A
• Market Cap: $3.77 billion
• Optionable: Not Optionable
• Beta: N/A